B2M and graft versus host disease: Disruption of the T-cell receptor alpha constant (TRAC) gene eliminates endogenous TCR expression and prevents GvHD, while knockout of β2-microglobulin (B2M) reduces expression of major histocompatibility complex (MHC) class I molecules, thereby mitigating HvG-mediated rejection [2].